GAS5 and metabolic dysfunction-associated steatotic liver disease: One study by Han et al. showed that both liver and plasma lncRNA GAS5 expression was positively correlated with the progression of liver fibrosis in 51 patients with NAFLD, and this was more apparent in plasma.